Dr. Mumtaz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
410 W 10th Ave
Columbus, OH 43210Phone+1 614-293-6255Fax+1 614-293-8518
Education & Training
- Dow University of Health SciencesClass of 1993
Certifications & Licensure
- OH State Medical License 2014 - 2023
Publications & Presentations
PubMed
- Impact of Preoperative Glucagon-Like Peptide-1 Receptor Agonist on Outcomes Following Major Surgery.Zayed Rashid, Selamawit Woldesenbet, Mujtaba Khalil, Abdullah Altaf, Jun Kawashima
World Journal of Surgery. 2025-01-09 - Does Weekend Discharge Affect Readmission and Survival in Liver Transplant Patients? Insights From a Cohort Study.Ayato Obana, Miho Akabane, Hannah Chi, Nolan Ladd, Matthew Yoder
Clinical Transplantation. 2025-01-01 - Impact of social vulnerability index on patients with alcohol-related liver disease.Ayushi Jain, Michael R Wellner, Jing Peng, Jianing Ma, Kenneth D Allen
Alcohol. 2024-12-01
Press Mentions
- Pandemic Drinking Triggers Surge in Liver TransplantsAugust 5th, 2021
- Mallinckrodt Presents Data on TERLIVAZ® (Terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 Digestive Disease Week® (DDW)May 22nd, 2024
- Mallinckrodt Presents Data on TERLIVAZ® (Terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 Digestive Disease Week® (DDW)May 22nd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: